152 related articles for article (PubMed ID: 11213967)
81. Interleukin 2 gene therapy of residual disease in mice carrying tumours induced by HPV 16.
Bubeník J; Símová J; Hájková R; Sobota V; Jandlová T; Smahel M; Sobotková E; Vonka V
Int J Oncol; 1999 Mar; 14(3):593-7. PubMed ID: 10024696
[TBL] [Abstract][Full Text] [Related]
82. Comparison of gene therapy with interleukin-2 gene modified fibroblasts and tumor cells in the murine CT-26 model of colorectal carcinoma.
Shawler DL; Dorigo O; Gjerset RA; Royston I; Sobol RE; Fakhrai H
J Immunother Emphasis Tumor Immunol; 1995 May; 17(4):201-8. PubMed ID: 7582256
[TBL] [Abstract][Full Text] [Related]
83. An experimental model of leptomeningeal metastases employing rat mammary carcinoma cells.
Sagar SM; Price KJ
J Neurooncol; 1995; 23(1):15-21. PubMed ID: 7623067
[TBL] [Abstract][Full Text] [Related]
84. An implantable guide-screw system for brain tumor studies in small animals.
Lal S; Lacroix M; Tofilon P; Fuller GN; Sawaya R; Lang FF
J Neurosurg; 2000 Feb; 92(2):326-33. PubMed ID: 10659021
[TBL] [Abstract][Full Text] [Related]
85. Neoadjuvant therapy with interleukin-12-loaded polylactic acid microspheres reduces local recurrence and distant metastases.
Sabel MS; Hill H; Jong YS; Mathiowitz E; Bankert RB; Egilmez NK
Surgery; 2001 Sep; 130(3):470-8. PubMed ID: 11562672
[TBL] [Abstract][Full Text] [Related]
86. Injection of colon carcinoma patients with autologous irradiated tumor cells and fibroblasts genetically modified to secrete interleukin-2 (IL-2): a phase I study.
Sobol RE; Royston I; Fakhrai H; Shawler DL; Carson C; Dorigo O; Gjerset R; Gold DP; Koziol J; Mercola D
Hum Gene Ther; 1995 Feb; 6(2):195-204. PubMed ID: 7734519
[No Abstract] [Full Text] [Related]
87. Estradiol increases IL-8 secretion of normal human breast tissue and breast cancer in vivo.
Bendrik C; Dabrosin C
J Immunol; 2009 Jan; 182(1):371-8. PubMed ID: 19109168
[TBL] [Abstract][Full Text] [Related]
88. Brain metastasis model in athymic nude mice using a novel MUC1-secreting human breast-cancer cell line, MA11.
Rye PD; Norum L; Olsen DR; Garman-Vik S; Kaul S; Fodstad O
Int J Cancer; 1996 Nov; 68(5):682-7. PubMed ID: 8938153
[TBL] [Abstract][Full Text] [Related]
89. Priming in the brain, an immunologically privileged organ, elicits anti-tumor immunity.
Fathallah-Shaykh HM; Gao W; Cho M; Herrera MA
Int J Cancer; 1998 Jan; 75(2):266-76. PubMed ID: 9462718
[TBL] [Abstract][Full Text] [Related]
90. EO771, is it a well-characterized cell line for mouse mammary cancer model? Limit and uncertainty.
Le Naour A; Rossary A; Vasson MP
Cancer Med; 2020 Nov; 9(21):8074-8085. PubMed ID: 33026171
[TBL] [Abstract][Full Text] [Related]
91. Cytokine Gene Vaccine Therapy for Treatment of a Brain Tumor.
Lichtor T; Tang B; Roy EJ
Brain Sci; 2023 Oct; 13(11):. PubMed ID: 38002466
[TBL] [Abstract][Full Text] [Related]
92. Gene therapy with cytokine-transfected xenogeneic cells in metastatic tumors.
Rochlitz CF; Jantscheff P; Bongartz G; Dietrich PY; Quiquerez AL; Schatz C; Mehtali M; Courtney M; Tartour E; Dorval T; Fridman WH; Herrmann R
Adv Exp Med Biol; 1998; 451():531-7. PubMed ID: 10026923
[TBL] [Abstract][Full Text] [Related]
93. Therapeutic effect of a single peritumoural dose of IL-2 on transplanted murine breast cancer.
Moiseeva EV; Merkulova IB; Bijleveld C; Koten JW; Miroshnikov AI; Den Otter W
Cancer Immunol Immunother; 2003 Aug; 52(8):487-96. PubMed ID: 12719897
[TBL] [Abstract][Full Text] [Related]
94. Anti-tumor effects and tumor immunogenicity following IL2 or IL4 cytokine gene transfection of three mouse mammary tumors.
Matory YL; Chen M; Goedegebuure PS; Eberlein TJ
Ann Surg Oncol; 1995 Nov; 2(6):502-11. PubMed ID: 8591080
[TBL] [Abstract][Full Text] [Related]
95. Local low-dose interleukin-2 induces systemic immunity when combined with radiotherapy of cancer. A pre-clinical study.
Everse LA; Renes IB; Jürgenliemk-Schulz IM; Rutgers DH; Bernsen MR; Dullens HF; Den Otter W; Battermann JJ
Int J Cancer; 1997 Sep; 72(6):1003-7. PubMed ID: 9378533
[TBL] [Abstract][Full Text] [Related]
96. A morphological and ultrastructural investigation of normal mouse brain tissue after intracerebral injection of tumor necrosis factor.
Yamasaki T; Kikuchi H; Moritake K; Nagao S; Iwasaki K; Paine JT; Kagawa T; Namba Y
J Neurosurg; 1992 Aug; 77(2):279-87. PubMed ID: 1625018
[TBL] [Abstract][Full Text] [Related]
97. Effect of intracerebrally injected Corynebacterium parvum on implanted brain tumor in mice.
Kennedy JD; Conley FK
J Neurooncol; 1989 May; 7(1):89-101. PubMed ID: 2502606
[TBL] [Abstract][Full Text] [Related]
98. In situ interleukin-4 gene expression in cancer patients treated with genetically modified tumor vaccine.
Suminami Y; Elder EM; Lotze MT; Whiteside TL
J Immunother Emphasis Tumor Immunol; 1995 May; 17(4):238-48. PubMed ID: 7582260
[TBL] [Abstract][Full Text] [Related]
99. A survey of in vivo growth characteristics and spontaneous metastasizing potentials of C3H mouse mammary tumors.
Vaage J
Int J Cancer; 1989 May; 43(5):910-4. PubMed ID: 2714897
[TBL] [Abstract][Full Text] [Related]
100. A novel animal model of human breast cancer metastasis to the spine: a pilot study using intracardiac injection and luciferase-expressing cells.
Zadnik P; Sarabia-Estrada R; Groves ML; Molina C; Jackson C; McCarthy E; Gokaslan ZL; Bydon A; Wolinsky JP; Witham TF; Sciubba DM
J Neurosurg Spine; 2013 Mar; 18(3):217-25. PubMed ID: 23259542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
